HEALTHIT.COM
Research
RESEARCH PREVIEW · 2026-08-27
Menu
2026-08-22Corti achieves ISO/IEC 27001◆2026-08-22Geisinger case: 70% faster prior auth TAT◆2026-08-22Infinitus SOC 2 Type II compliance◆2026-08-22AKASA HITRUST/SOC 2 and 100% pre-bill review◆2026-08-22Infinitus 2025 recap: 1.17M patients automated◆2026-08-22HIPAA/SOC 2 Type II; recordings deleted◆2026-08-19Luma-PCC partnership to bring AI-enabled communications to 300+ pediatric practices◆2026-08-15Glass ranks top-tier on ARISE NOHARM clinical safety benchmark◆2026-08-15ISO 27001, HIPAA, 7+ FDA 510(k)s documented◆2026-08-15UpToDate integrated into Epic EHR/MyChart and ambient AI workflows◆2026-08-06UpToDate Expert AI adopted by ~2,500 U.S. hospitals and health systems◆2026-07-292.7M weekly interactions; US CAB launch◆2026-07-23Anterior-Stellarus partnership◆2026-07-23Strategic partnership with Stellarus to enable real-time AI-driven prior authorization for health plans◆2026-07-22Waystar Q2 2026 beat; AI anomaly detection traction◆2026-07-21Patient Pipeline: AI-powered new patient acquisition from ad spend to booked care◆2026-07-21Luma launches AI Patient Pipeline for new patient acquisition◆2026-07-07SMART on FHIR + Epic Toolbox integration◆2026-06-30Nature Health SAFEMOM study shows Ada improves health-seeking behavior on MomConnect◆2026-06-26Modality Partnership (NHS) rolls out Heidi across 53 sites in the UK's largest clinical deployment of ambient AI◆2026-06-26NHS Modality Partnership rollout◆2026-06-24Roche acquires PathAI for ~$1B to bolster AI-based diagnostic algorithms◆2026-06-24Assort Health raises $120M Series C at $1.2B valuation◆2026-06-15Thoreau Group signs $12B agreement to take control of Ensemble Health◆
Evidence explorer

Every claim we hold, and how far we can stand behind it.

142 claims across 39 products. 30% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.

What this corpus is made of
Evidence classClaimsConfirmedWhat it can support
Peer-reviewed study195Independent review before publication. The only class that survives a sceptical committee unaided.
Regulatory filing40A statement made to a regulator, where being wrong has consequences.
Independent report329Analysis by someone with no stake in the sale.
Customer case43A real deployment, but selected and framed by someone with an interest.
Press release6323The vendor's own announcement. Useful for dates and facts, not for outcomes.
Vendor page202Marketing copy. Establishes what is claimed, never that it is true.

Showing 8 of 8 matching claims (142 in the full corpus) · 13% of this selection is confirmed · clear filters

  1. Wolters Kluwer launched UpToDate Expert AI (GenAI clinical decision support), initially available to Enterprise Edition customers from Q4 2025.

    UpToDate Expert AIPress releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_9a678a93ecd11a7d462a
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    interoperability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.wolterskluwer.com/en/news/uptodate-expert-ai-genai-clinical-decision-support

  2. Approximately 2,500 U.S. hospitals and health systems - over 90% of U.S. UpToDate Enterprise Edition customers - have adopted UpToDate Expert AI, including Sharp HealthCare, Duke University Health System, University of Iowa Health Care, and Intermountain Health (34 sites)

    UpToDate Expert AIPress releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_8e0ef3bd123ceba43277
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    deployment traction
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://markets.ft.com/data/announce/detail?dockey=600-202608060930BIZWIRE_USPRX____20260806_BW987931-1

  3. Since launching in September 2025, Wolters Kluwer has been working with more than 50 major U.S. health systems to deploy UpToDate Expert AI enterprise-wide, and added comprehensive medication information from UpToDate Lexidrug (~3,000 drug topics) to the AI

    UpToDate Expert AIPress releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_5ec75a7962d25f6855a0
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    deployment traction
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.wolterskluwer.com/en/news/uptodate-expert-ai-genai-clinical-decision-support

  4. Wolters Kluwer launched UpToDate Expert AI, a generative AI CDS solution grounded solely in UpToDate evidence-based content with transparent assumptions and rationale, available to select UpToDate Enterprise Edition customers beginning Q4 2025

    UpToDate Expert AIPress releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_320b2741e1f8af156542
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    general
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.wolterskluwer.com/en/news/uptodate-expert-ai-genai-clinical-decision-support

  5. Glass AI launched a Developer API for its clinical decision support platform, enabling third parties to build custom integrations (including ambient scribing workflows)

    Glass AI (clinical decision support, differential diagnosis & ambient scribing)Press releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_908a501ff7ccd0b4b6f7
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    interoperability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.linkedin.com/posts/glass-health-inc_glass-health-developer-api-ambient-scribing-activity-7382480136790515712-_nDE

  6. Infermedica was named to AVIA Marketplace's 2024 Top Clinical Decision Support Companies list

    Infermedica Medical Guidance Platform (triage, intake, follow-up) incl. Conversational TriagePress releaseConfirmedOpen source ↗
    Provenance
    Claim ID
    clm_3c80a940dcc5c13cfb92
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    market durability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.prnewswire.com/news-releases/infermedica-named-to-avia-marketplaces-2024-top-clinical-decision-support-companies-302280884.html

  7. Ada's medical AI solutions are available on the Epic App Orchard marketplace using SMART on FHIR open standards, with single sign-on (SSO) supporting integration into MyChart patient portals

    Ada Health Assessment (AI symptom assessment & care navigation)Press releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_0b65d1c12b422b4a5960
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    interoperability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://about.ada.com/press/220315-ada-healths-medical-ai-solutions-now-available-on-epic-app-orchard

  8. Ada closed its Series B at $120M: $90M led by Leaps by Bayer (May 2021) plus a $30M extension from Farallon Capital, Red River West and Bertelsmann Investments (Feb 2022), with Schroders Capital acquiring secondary shares; total funding ~$189M

    Ada Health Assessment (AI symptom assessment & care navigation)Press releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_fb263852bb4e2fd81471
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    market durability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://about.ada.com/press/220210-ada-health-extends-series-b-to-120-million
Know a source we are missing?

Open to everyone — no account needed. This is a non-PHI service: never include patient identifiers.

We cannot action an evidence claim without something to check.